Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis

Publication Details

Available from: The New England Journal of Medicine 2011 Oct 20; 365(16): 1482–1491. doi:  10.1056/NEJMoa1013607

Link to Source
Author
Diane V. Havlir, Michelle A. Kendall, Prudence Ive, Johnstone Kumwenda, Susan Swindells, Sarojini S. Qasba, Anne F. Luetkemeyer, Evelyn Hogg, James F. Rooney, Xingye Wu, Mina C. Hosseinipour, Umesh Lalloo, Valdilea G. Veloso, Fatuma F. Some, N. Kumarasamy, Nesri Padayatchi, Breno R. Santos, Stewart Reid, James Hakim, Lerato Mohapi, Peter Mugyenyi, Jorge Sanchez, Javier R. Lama, Jean W. Pape, Alejandro Sanchez, Aida Asmelash, Evans Moko, Fred Sawe, Janet Andersen and Ian Sanne, Peterman
Country
Botswana, Brazil, Haiti, India, Kenya, Malawi, Peru, South Africa, Uganda, Zambia, Zimbabwe
Region
South Asia, Sub-Saharan Africa (includes East and West Africa), Latin America and the Caribbean
Sector
Health Nutrition and Population
Subsector
HIV and AIDS, Specific Diseases- including Malaria TB
Equity Focus
Sexual minorities
Evaluation design
Randomised Control Trials (RCT)
Status
Journal Article
Scroll to Top